News

Up-to-date news about Intravacc

Stay informed about the latest developments in our mission to pioneer transformative vaccines with up-to-date corporate communications. Get the latest news on our development and business milestones, as well as industry insights, partnership announcements, and corporate reports.

Category icon
Corporate

We interviewed Paul, our new Director QA/QC & EHS to learn about his career and his passion for quality.

Category icon
Press releases

Intravacc secures $633K funding from CARB-X to develop a vaccine against Neisseria gonorrhoeae.

Category icon
Corporate

On the third of May last year the Ministry of Health, Welfare, and Sport (VWS) announced the sale of Intravacc B.V. and on December 28, 2023 VWS…

Category icon
Press releases

Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention

Category icon
Partnership

Enabling Tech Transfer of B. pertussis OMV Technology to our Partner Chonquing Zhifei Biological Products

Contact us

You can send us an email:
info@intravacc.nl

Reach out to Business Development: 
BD@intravacc.nl

Or pick up the phone: 
+31 30 792 03 00

You can also just fill out the contact form on the right.

We look forward to hearing from you!

 

Contact form

Subscribe to our newsletter